4//SEC Filing
Bergstein Ivan 4
Accession 0001104659-19-046425
CIK 0001264587other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 9:30 PM ET
Size
5.7 KB
Accession
0001104659-19-046425
Insider Transaction Report
Form 4
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
- Sale
Common Stock
2019-08-14$14.73/sh−35,010$515,697→ 2,570,801 total
Footnotes (3)
- [F1]In connection with the vesting of 62,500 shares on August 13, 2019, a total of 35,010 shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for such transaction is $14.50 to $15.44. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 2,570,801 shares, 687,200 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001554767
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 9:30 PM ET
- Size
- 5.7 KB